NCT05021757View on ClinicalTrials.gov

Disrupt CAD III Post-Approval Study (PAS)

CompletedOBSERVATIONAL
Enrollment

1,212

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Coronary Artery DiseaseMyocardial Infarction
Interventions
DEVICE

Shockwave C2 Coronary IVL

PCI procedure using a Shockwave C2 coronary IVL catheter

Trial Locations (1)

20037

American College of Cardiology/National Cardiovascular Data Registry (NCDR), Washington D.C.

All Listed Sponsors
lead

Shockwave Medical, Inc.

INDUSTRY

NCT05021757 - Disrupt CAD III Post-Approval Study (PAS) | Biotech Hunter | Biotech Hunter